Mechanism of progression of renal disease: Current hemodynamic concepts

Journal of Hypertension, Supplement

Volumn 16, Issue 4, 1998, Pages

  Johnston, Colin I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin; Angiotensin converting enzyme inhibitors; Antihypertensive agents; Blood pressure; Disease progression; End stage renal disease; Glomerular hypertension; Hemodynamics; Renal disease; Renin angiotensin system

Indexed keywords

CONFERENCE PAPER; DISEASE COURSE; ENDOTHELIUM; GLOMERULUS; HEMODYNAMICS; HYPERTENSION; KIDNEY DISEASE; MECHANICAL STRESS; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

ANIMALS; ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; KIDNEY DISEASES; RENIN-ANGIOTENSIN SYSTEM;

EID: 0031788869     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Perry HM Jr, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 1995; 25:587-594.
2. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, er al. Blood pressure and end-stage renal disease in men. N EnglJ Med 1996; 334:13-18.
3. Olson JL, Wilson SK, Heptinstall RH. Relation of glomerular injury to preglomerular resistance in experimental hypertension. Kidney Int 1986; 29:849-857.
4. Brenner BM, MeyerTW, Hosteller TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N EnglJ Med 1982; 307:652-659.
5. Egido J. Vasoactive hormones and renal sclerosis. Kidney Int 1996; 49:578-597.